{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T23:03:10Z","timestamp":1771023790729,"version":"3.50.1"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005187","name":"National and Kapodistrian University of Athens","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005187","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.msard.2022.103858","type":"journal-article","created":{"date-parts":[[2022,5,8]],"date-time":"2022-05-08T17:37:11Z","timestamp":1652031431000},"page":"103858","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["HLA-genotyping by next-generation-sequencing reveals shared and unique HLA alleles in two patients with coexisting neuromyelitis optica spectrum disorder and thymectomized myasthenia gravis: Immunological implications for mutual aetiopathogenesis?"],"prefix":"10.1016","volume":"63","author":[{"given":"Aigli","family":"Vakrakou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theofanis","family":"Chatzistamatiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Koros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitris","family":"Karathanasis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasileios","family":"Tentolouris-Piperas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Tzanetakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panos","family":"Stathopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Koutsis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Spyropoulou-Vlachou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria-Eleftheria","family":"Evangelopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonidas","family":"Stefanis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Stavropoulos-Giokas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Anagnostouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.msard.2022.103858_bib0076","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1212\/WNL.0000000000001587","article-title":"Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis","volume":"85","author":"Absinta","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2022.103858_bib0065","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/tan.13065","article-title":"Different DRB1*03:01-DQB1*02:01 haplotypes confer different risk for celiac disease","volume":"90","author":"Alshiekh","year":"2017","journal-title":"HLA"},{"key":"10.1016\/j.msard.2022.103858_bib0046","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2017.05.018","article-title":"The HLA DRB1*03:01 allele is associated with NMO regardless of the NMO-IgG status in Brazilian patients from Rio de Janeiro","volume":"310","author":"Alvarenga","year":"2017","journal-title":"J. Neuroimmunol."},{"issue":"2","key":"10.1016\/j.msard.2022.103858_bib0042","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/jns5.12061","article-title":"HLA-DRB1* alleles genotyping in chronic inflammatory demyelinating polyneuropathy in Greek patients","volume":"19","author":"Anagnostouli","year":"2014","journal-title":"J. Peripher. Nerv. Syst. JPNS"},{"key":"10.1016\/j.msard.2022.103858_bib0041","first-page":"1","article-title":"Myasthenia gravis, atypical polyneuropathy and multiple autoimmune phenomena in the same patient, with HLA-immunogenetic profile expectable for Greek chronic inflammatory demyelinating polyneuropathy: a case report","volume":"14","author":"Anagnostouli","year":"2020","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.msard.2022.103858_bib0058","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci10060374","article-title":"HLA-DPB1*03 as risk allele and HLA-DPB1*04 as protective allele for both early- and adult-onset multiple sclerosis in a Hellenic cohort","volume":"10","author":"Anagnostouli","year":"2020","journal-title":"Brain Sci."},{"key":"10.1016\/j.msard.2022.103858_bib0004","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1093\/ejcts\/ezu530","article-title":"Predictive factors of myasthenic crisis after extended thymectomy for patients with myasthenia gravis","volume":"48","author":"Ando","year":"2015","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.msard.2022.103858_bib0073","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000343","article-title":"Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder","volume":"4","author":"Asgari","year":"2017","journal-title":"Neurol. Neuroimmunol. NeuroInflamm."},{"key":"10.1016\/j.msard.2022.103858_bib0060","first-page":"B4730","article-title":"Epidemiological, clinical and immunological aspects of neuromyelitis optica (NMO)","volume":"60","author":"Asgari","year":"2013","journal-title":"Dan. Med. J."},{"key":"10.1016\/j.msard.2022.103858_bib0029","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-11-3900","article-title":"Functional defect of regulatory CD4(+)CD25+ T cells in the thymus of patients with autoimmune myasthenia gravis","volume":"105","author":"Balandina","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.msard.2022.103858_bib0056","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41598-021-04074-1","article-title":"Tatsusada Okuno & Hideki Mochizuki High cell surface expression and peptide binding affinity of HLA-DQA1*05:03, a susceptible allele of neuromyelitis optica spectrum disorders (NMOSD)","volume":"12","author":"Beppu","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.msard.2022.103858_bib0077","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awab045","article-title":"Imaging meningeal inflammation in CNS autoimmunity identifies a therapeutic role for BTK inhibition","author":"Bhargava","year":"2021","journal-title":"Brain"},{"key":"10.1016\/j.msard.2022.103858_bib0038","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.msard.2018.12.028","article-title":"Neuromyelitis optica spectrum disorder presenting with concurrent autoimmune diseases","volume":"28","author":"Bibic","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2022.103858_bib0061","first-page":"146","article-title":"[HLA-DRB1 typing in Caucasians patients with neuromyelitis optica]","volume":"53","author":"Blanco","year":"2011","journal-title":"Rev. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2022.103858_bib0020","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1016\/j.jfo.2018.06.018","article-title":"[Neuromyelitis optica spectrum disorders positive for anti-AQP4 antibody associated with myasthenia gravis: A literature review]","volume":"42","author":"Brignol","year":"2019","journal-title":"J. Fr. Ophtalmol."},{"key":"10.1016\/j.msard.2022.103858_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102173","article-title":"Neuromyelitis optica in patients with myasthenia gravis: two case-reports","volume":"43","author":"Castro-Suarez","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"3","key":"10.1016\/j.msard.2022.103858_bib0032","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1474-9726.2011.00677.x","article-title":"Novel role of aquaporin-4 in CD4+ CD25+ T regulatory cell development and severity of Parkinson's disease","volume":"10","author":"Chi","year":"2011","journal-title":"Aging Cell"},{"issue":"3","key":"10.1016\/j.msard.2022.103858_bib0010","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/brain\/103.3.579","article-title":"Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis","volume":"103","author":"Compston","year":"1980","journal-title":"Brain"},{"key":"10.1016\/j.msard.2022.103858_bib0031","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/nyas.13519","article-title":"Thymus involvement in early-onset myasthenia gravis","author":"Cron","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.msard.2022.103858_bib0069","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jns.2015.11.021","article-title":"Association of HLA class II (DRB1, DQA1, DQB1) alleles and haplotypes with myasthenia gravis and its subgroups in the Iranian population","volume":"359","author":"Ehsan","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2022.103858_bib0057","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1038\/s41467-018-04332-3","article-title":"A whole-genome sequence study identifies genetic risk factors for neuromyelitis optica","volume":"9","author":"Estrada","year":"2018","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.msard.2022.103858_bib0074","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3109\/00207454.2015.1055356","article-title":"Dynamic change in magnetic resonance imaging of patients with neuromyelitis optica","volume":"126","author":"Fan","year":"2016","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.msard.2022.103858_bib0007","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0140-6736(74)92548-3","article-title":"HL-A antigens in myasthenia gravis","volume":"1","author":"Fritze","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.msard.2022.103858_bib0035","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0091-6749(99)70431-8","article-title":"Long-term immunologic effects of thymectomy in patients with myasthenia gravis","volume":"103","author":"Gerli","year":"1999","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.msard.2022.103858_bib0006","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized trial of thymectomy in myasthenia gravis","volume":"375","author":"Wolfe","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.msard.2022.103858_bib0062","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4103\/2347-8659.139713","article-title":"Human leukocyte antigens\u2011immunogenetics of neuromyelitis optica or Devic's disease and the impact on the immunopathogenesis, diagnosis and treatment: a critical review","volume":"1","author":"Gontika","year":"2014","journal-title":"Neuroimmunol. Neuroinflammation."},{"key":"10.1016\/j.msard.2022.103858_bib0016","article-title":"HLA-DRB1 allele impact on pediatric multiple sclerosis in a Hellenic cohort","volume":"6","author":"Gontika","year":"2020","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"key":"10.1016\/j.msard.2022.103858_bib0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jaut.2013.12.015","article-title":"Both Treg cells and Tconv cells are defective in the myasthenia gravis thymus: roles of IL-17 and TNF-\u03b1","volume":"52","author":"Gradolatto","year":"2014","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/j.msard.2022.103858_bib0011","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ana.26169","article-title":"Julian C knight genomic insights into myasthenia gravis identify distinct immunological mechanisms in early and late onset disease","volume":"90","author":"Handunnetthi","year":"2021","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.msard.2022.103858_bib0072","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/jon.12444","article-title":"Leptomeningeal enhancement at 7T in multiple sclerosis: frequency, morphology, and relationship to cortical volume","volume":"27","author":"Harrison","year":"2017","journal-title":"J. Neuroimaging."},{"key":"10.1016\/j.msard.2022.103858_bib0018","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.clineuro.2014.07.036","article-title":"Japanese cases of neuromyelitis optica spectrum disorder associated with myasthenia gravis and a review of the literature","volume":"125","author":"Ikeguchi","year":"2014","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.msard.2022.103858_bib0002","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/08916934.2014.883501","article-title":"A review of the current literature and a guide to the early diagnosis of autoimmune disorders associated with neuromyelitis optica","volume":"47","author":"Iyer","year":"2014","journal-title":"Autoimmunity"},{"key":"10.1016\/j.msard.2022.103858_bib0039","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nri1805","article-title":"MHC class II proteins and disease: a structural perspective","volume":"6","author":"Jones","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.msard.2022.103858_bib0067","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1590\/0004-282x20190031","article-title":"HLA-alleles class I and II associated with genetic susceptibility to neuromyelitis optica in Brazilian patients","volume":"77","author":"Kay","year":"2019","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.msard.2022.103858_bib0021","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/archneur.63.6.851","article-title":"Neuromyelitis optica in patients with myasthenia gravis who underwent thymectomy","volume":"63","author":"Kister","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.msard.2022.103858_bib0064","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1681\/ASN.2016060644","article-title":"HLA-DRB1*15:01 and HLA-DRB3*02:02 in PLA2R-related membranous nephropathy","volume":"28","author":"Le","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.msard.2022.103858_bib0003","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1212\/WNL.0b013e31825644ff","article-title":"Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients","volume":"78","author":"Leite","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2022.103858_bib0005","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1093\/ejcts\/ezt641","article-title":"Thymectomy in myasthenia gravis: proposal for a predictive score of postoperative myasthenic crisis","volume":"45","author":"Leuzzi","year":"2014","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.msard.2022.103858_bib0034","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/acn3.51055","article-title":"Risk of incident autoimmune diseases in patients with thymectomy","volume":"7","author":"Lin","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"1-2","key":"10.1016\/j.msard.2022.103858_bib0075","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jneuroim.2014.02.006","article-title":"Brain gadolinium enhancement along the ventricular and leptomeningeal regions in patients with aquaporin-4 antibodies in cerebral spinal fluid","volume":"269","author":"Long","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2022.103858_bib0017","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0165-5728(98)00120-9","article-title":"The impact of HLA on long-term outcome after thymectomy for myasthenia gravis","volume":"88","author":"Machens","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2022.103858_bib0052","doi-asserted-by":"crossref","first-page":"e36603","DOI":"10.1371\/journal.pone.0036603","article-title":"Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population","volume":"7","author":"Maniaol","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.msard.2022.103858_bib0026","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.autrev.2013.03.007","article-title":"The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes","volume":"12","author":"Marx","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.msard.2022.103858_bib0068","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s00415-019-09225-z","article-title":"Thymomatous myasthenia gravis: novel association with HLA DQB1*05:01 and strengthened evidence of high clinical and serological severity","volume":"266","author":"Massa","year":"2019","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2022.103858_bib0066","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1177\/1352458510374340","article-title":"HLA-DRB1*1501 tagging rs3135388 polymorphism is not associated with neuromyelitis optica","volume":"16","author":"Matiello","year":"2010","journal-title":"Mult. Scler."},{"issue":"7","key":"10.1016\/j.msard.2022.103858_bib0023","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/gene.2015.28","article-title":"Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes","volume":"16","author":"Miller","year":"2015","journal-title":"Genes Immun."},{"key":"10.1016\/j.msard.2022.103858_bib0025","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13317-019-0124-6","article-title":"Associations between HLA and autoimmune neurological diseases with autoantibodies","volume":"11","author":"Mu\u00f1iz-Castrillo","year":"2020","journal-title":"Auto. Immun. Highlights"},{"key":"10.1016\/j.msard.2022.103858_bib0022","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/NRL.0b013e318247bc91","article-title":"Anti-aquaporin-4 antibody-positive definite neuromyelitis optica in a patient with thymectomy for myasthenia gravis","volume":"18","author":"Ogaki","year":"2012","journal-title":"Neurologist"},{"key":"10.1016\/j.msard.2022.103858_bib0055","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12974-019-1551-z","article-title":"Next-generation sequencing identifies contribution of both class I and II HLA genes on susceptibility of multiple sclerosis in Japanese","volume":"16","author":"Ogawa","year":"2019","journal-title":"J. Neuroinflammation."},{"key":"10.1016\/j.msard.2022.103858_bib0027","doi-asserted-by":"crossref","first-page":"5941","DOI":"10.4049\/jimmunol.174.10.5941","article-title":"Effects of cytokines on acetylcholine receptor expression: implications for myasthenia gravis","volume":"174","author":"Po\u00eba-Guyon","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.msard.2022.103858_bib0008","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1600-065X.1999.tb01398.x","article-title":"The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases","volume":"167","author":"Price","year":"1999","journal-title":"Immunol. Rev."},{"issue":"4","key":"10.1016\/j.msard.2022.103858_bib0044","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0198-8859(93)90130-S","article-title":"Molecular analysis of HLA class II genes in primary Sj\u00f6gren's syndrome. A study of Israeli Jewish and Greek non-Jewish patients","volume":"36","author":"Roitberg-Tambur","year":"1993","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.msard.2022.103858_bib0028","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0165-5728(91)90165-4","article-title":"Antibodies to thymic epithelial cells in myasthenia gravis","volume":"35","author":"Safar","year":"1991","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2022.103858_bib0033","doi-asserted-by":"crossref","first-page":"14781","DOI":"10.1073\/pnas.1617859114","article-title":"Tolerance checkpoint bypass permits emergence of pathogenic T cells to neuromyelitis optica autoantigen aquaporin-4","volume":"113","author":"Sagan","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"10.1016\/j.msard.2022.103858_bib0050","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.clim.2016.05.003","article-title":"Genetic heterogeneity within the HLA region in three distinct clinical subgroups of myasthenia gravis","volume":"166-167","author":"Saruhan-Direskeneli","year":"2016","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.msard.2022.103858_bib0051","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2119\/molmed.2015.00232","article-title":"Genome-wide association study of late-onset myasthenia gravis: confirmation of TNFRSF11A and identification of ZBTB10 and three distinct HLA associations","volume":"21","author":"Seldin","year":"2016","journal-title":"Mol. Med."},{"key":"10.1016\/j.msard.2022.103858_bib0037","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.4049\/jimmunol.166.4.2808","article-title":"Effect of thymectomy on human peripheral blood T cell pools in myasthenia gravis","volume":"166","author":"Sempowski","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.msard.2022.103858_bib0071","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/acn3.51241","article-title":"CD8+ T cell subpopulations and pro-inflammatory cytokines in neuromyelitis optica spectrum disorder","volume":"8","author":"Shi","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.msard.2022.103858_bib0014","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3233\/JND-210700","article-title":"Association of HLA class II alleles with disease severity and treatment response in Iranian patients with myasthenia gravis","volume":"8","author":"Sinaei","year":"2021","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.msard.2022.103858_bib0024","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.msard.2013.01.003","article-title":"Myasthenia gravis and neuromyelitis opica: a causal link","volume":"2","author":"Spillane","year":"2013","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2022.103858_bib0012","first-page":"116","article-title":"HLA-genotype in multiple sclerosis: the role in disease onset, clinical course, cognitive status and response to treatment: a clear step towards personalized therapeutics","volume":"2","author":"Stamatelos","year":"2017","journal-title":"Immunogenet. Open Access."},{"key":"10.1016\/j.msard.2022.103858_bib0049","doi-asserted-by":"crossref","first-page":"15464","DOI":"10.1073\/pnas.0406756101","article-title":"Pleiotropic effects of the 8.1 HLA haplotype in patients with autoimmune myasthenia gravis and thymus hyperplasia","volume":"101","author":"Vandiedonck","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"10.1016\/j.msard.2022.103858_bib0009","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jaut.2017.10.002","article-title":"Novel genetic loci associated HLA-B*08:01 positive myasthenia gravis","volume":"88","author":"Varade","year":"2018","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.msard.2022.103858_bib0036","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ana.23651","article-title":"Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter","volume":"72","author":"Varrin-Doyer","year":"2012","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.msard.2022.103858_bib0043","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/ard.59.5.359","article-title":"Systemic scleroderma in Greece: low mortality and strong linkage with HLA-DRB1*1104 allele","volume":"59","author":"Vlachoyiannopoulos","year":"2000","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.msard.2022.103858_bib0040","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(13)60954-X","article-title":"Immunopathogenic mechanisms of systemic autoimmune disease","volume":"382","author":"Wahren-Herlenius","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.msard.2022.103858_bib0063","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01785","article-title":"Immunopathogenesis in myasthenia gravis and neuromyelitis optica","volume":"8","author":"Wang","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2022.103858_bib0048","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jneuroim.2010.11.004","article-title":"HLA-DPB1 0501 is associated with susceptibility to anti-aquaporin-4 antibodies positive neuromyelitis optica in southern Han Chinese","volume":"233","author":"Wang","year":"2011","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2022.103858_bib0015","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41598-020-79833-7","article-title":"HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS\/NMOSD Biobank data","volume":"11","author":"Watanabe","year":"2021","journal-title":"Sci. Rep"},{"key":"10.1016\/j.msard.2022.103858_bib0013","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1590\/0004-282x20180103","article-title":"Multiple sclerosis: disease modifying therapy and the human leukocyte antigen","volume":"76","author":"Werneck","year":"2018","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.msard.2022.103858_bib0001","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2022.103858_bib0054","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.jocn.2011.05.002","article-title":"Association between HLA-DRB1 and myasthenia gravis in a northern Han Chinese population","volume":"18","author":"Xie","year":"2011","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.msard.2022.103858_bib0047","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/jnnp-2012-302925","article-title":"Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status","volume":"84","author":"Yoshimura","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2022.103858_bib0045","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1177\/1352458508102085","article-title":"Is neuromyelitis optica associated with human leukocyte antigen","volume":"15","author":"Z\u00e9phir","year":"2009","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2022.103858_bib0070","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.4049\/jimmunol.1500725","article-title":"Augmentation of circulating follicular helper T cells and their impact on autoreactive B cells in myasthenia gravis","volume":"197","author":"Zhang","year":"2016","journal-title":"J. Immunol."},{"key":"10.1016\/j.msard.2022.103858_bib0053","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jneuroim.2012.03.018","article-title":"HLA-DQA1*03:02\/DQB1*03:03:02 is strongly associated with susceptibility to childhood-onset ocular myasthenia gravis in Southern Han Chinese","volume":"247","author":"Zhu","year":"2012","journal-title":"J. Neuroimmunol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822003704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822003704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:07:10Z","timestamp":1761901630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034822003704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":76,"alternative-id":["S2211034822003704"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2022.103858","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HLA-genotyping by next-generation-sequencing reveals shared and unique HLA alleles in two patients with coexisting neuromyelitis optica spectrum disorder and thymectomized myasthenia gravis: Immunological implications for mutual aetiopathogenesis?","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2022.103858","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103858"}}